Prostate Cancer - Results from #26400

GU Cancers Symposium 2012 - Sequencing of therapies in men with castration-resistant prostate cancer - Session Highlights February 3, 2012

GU Cancers Symposium 2012 - Castration-resistant prostate cancer: Novel targets, agents, and trials - Session Highlights February 3, 2012

GU Cancers Symposium 2012 - A Randomized phase II study of OGX-427 + prednisone vs. prednisone alone in patients with chemotherapy-naive metastatic castration resistant prostate cancer - Poster February 3, 2012

GU Cancers Symposium 2012 - Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort - Poster February 3, 2012

Myriad’s Prolaris® test shown to significantly predict biochemical recurrence risk after prostatectomy February 3, 2012

GU Cancers Symposium 2012 - Role of dose escalation and supplemental androgen deprivation - Session Highlights February 3, 2012

GU Cancers Symposium 2012 - Hypofractionation for prostate cancer: Is less better? - Session Highlights February 3, 2012

Rubin H. Flocks and colloidal gold treatments for prostate cancer - Abstract February 2, 2012

Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging - Abstract February 2, 2012

The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study - Abstract February 2, 2012

Frequency and determinants of disagreement and error in Gleason scores: A population-based study of prostate cancer - Abstract February 2, 2012

Quantitative RT-PCR analysis of PSA and prostate-specific membrane antigen mRNA to detect circulating tumor cells improves recurrence-free survival nomogram prediction after radical prostatectomy - Abstract February 2, 2012

Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies - Abstract February 2, 2012

Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: Comparison to prostatic biopsy - Abstract February 2, 2012

Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer - Abstract February 2, 2012

Factors implicated in radiation therapy failure and radiosensitization of prostate cancer - Abstract February 2, 2012

Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced (18)F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy - Abstract February 2, 2012

Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model - Abstract February 2, 2012

Prognostic determinants in prostate cancer - Abstract February 2, 2012

Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer - Abstract February 2, 2012

Page 1321 of 1438